<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36764301</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects.</ArticleTitle><Pagination><StartPage>1191</StartPage><EndPage>1204.e5</EndPage><MedlinePgn>1191-1204.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.01.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00034-X</ELocationID><Abstract><AbstractText>Using induced pluripotent stem cells (iPSCs) to understand the mechanisms of neurological disease holds great promise; however, there is a lack of well-curated lines from a large array of participants. Answer ALS has generated over 1,000 iPSC lines from control and amyotrophic lateral sclerosis (ALS) patients along with clinical and whole-genome sequencing data. The current report summarizes cell marker and gene expression in motor neuron cultures derived from 92 healthy control and 341 ALS participants using a 32-day differentiation protocol. This is the largest set of iPSCs to be differentiated into motor neurons, and characterization suggests that cell composition and sex are significant sources of variability that need to be carefully controlled for in future studies. These data are reported as a resource for the scientific community that will utilize Answer ALS data for disease modeling using a wider array of omics being made available for these samples.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Workman</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>The Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Ryan G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of California, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ornelas</LastName><ForeName>Loren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panther</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvez</LastName><ForeName>Erick</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meepe</LastName><ForeName>Imara</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valencia</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Emilda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chunyan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moran</LastName><ForeName>Ruby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinedo</LastName><ForeName>Louis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsitkov</LastName><ForeName>Stanislav</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ritchie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaye</LastName><ForeName>Julia A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for Systems and Therapeutics, Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA; Taube/Koret Center for Neurodegenerative Disease, Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA; Departments of Neurology and Physiology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Answer ALS Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Terri</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>On Point Scientific Inc., San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothstein</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finkbeiner</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Systems and Therapeutics, Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA; Taube/Koret Center for Neurodegenerative Disease, Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA; Departments of Neurology and Physiology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraenkel</LastName><ForeName>Ernest</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sareen</LastName><ForeName>Dhruv</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: dhruv.sareen@cshs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Leslie M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, USA; Department of Biological Chemistry, University of California, Irvine, CA, USA; Department of Neurobiology and Behavior, University of California, Irvine, CA, USA; Department of Psychiatry and Human Behavior and Sue and Bill Gross Stem Cell Center, University of California, Irvine, CA, USA. Electronic address: lmthomps@uci.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svendsen</LastName><ForeName>Clive N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>The Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: clive.svendsen@cshs.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AR075047</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 CA217378</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD010794</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD021718</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR025496</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA062203</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">iPSC</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">sex differences</Keyword></KeywordList><CoiStatement>Declaration of interests US patent 10,221,395-B2 has been granted describing a method for reprogramming blood to induced pluripotent stem cells. Apart from this issued patent filing, the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36764301</ArticleId><ArticleId IdType="mid">NIHMS1930043</ArticleId><ArticleId IdType="pmc">PMC10557526</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.01.010</ArticleId><ArticleId IdType="pii">S0896-6273(23)00034-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Giacomelli E, Vahsen BF, Calder EL, Xu Y, Scaber J, Gray E, Dafinca R, Talbot K, and Studer L (2022). Human stem cell models of neurodegeneration: from basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell 29, 11&#x2013;35. 10.1016/j.stem.2021.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.008</ArticleId><ArticleId IdType="pmc">PMC8785905</ArticleId><ArticleId IdType="pubmed">34995492</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, Li Y, Chang WH, Hung ST, Hendricks E, Linares GR, Wang Y, Son EY, et al. (2018). Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 24, 313&#x2013;325. 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T, Hadano S, Aoki M, Saya H, Sobue G, and Okano H (2018). Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 24, 1579&#x2013;1589. 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang EA, Tomov ML, Suhr ST, Luo J, Olmsted ZT, Paluh JL, and Cibelli J (2015). Derivation of ethnically diverse human induced pluripotent stem cell lines. Sci. Rep. 5, 15234. 10.1038/srep15234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15234</ArticleId><ArticleId IdType="pmc">PMC5388175</ArticleId><ArticleId IdType="pubmed">26482195</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxi EG, Thompson T, Li J, Kaye JA, Lim RG, Wu J, Ramamoorthy D, Lima L, Vaibhav V, Matlock A, et al. (2022). Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nat. Neurosci. 25, 226&#x2013;237. 10.1038/s41593-021-01006-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-01006-0</ArticleId><ArticleId IdType="pmc">PMC8825283</ArticleId><ArticleId IdType="pubmed">35115730</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S, Bruijn LI, Chandran S, Eggan K, Ho R, Klim JR, Livesey MR, Lowry E, Macklis JD, Rushton D, et al. (2016). Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat. Neurosci. 19, 542&#x2013;553. 10.1038/nn.4273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4273</ArticleId><ArticleId IdType="pmc">PMC5015775</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId></ArticleIdList></Reference><Reference><Citation>Toombs J, Panther L, Ornelas L, Liu C, Gomez E, Mart&#xed;n-Ib&#xe1;&#xf1;ez R, Cox SR, Ritchie SJ, Harris SE, Taylor A, et al. (2020). Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936. Stem Cell Res. 46, 101851. 10.1016/j.scr.2020.101851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2020.101851</ArticleId><ArticleId IdType="pmc">PMC7347008</ArticleId><ArticleId IdType="pubmed">32450543</ArticleId></ArticleIdList></Reference><Reference><Citation>Michetti F, D&#x2019;Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, Corvino V, and Geloso MC (2019). The S100B story: from biomarker to active factor in neural injury. J. Neurochem. 148, 168&#x2013;187. 10.1111/jnc.14574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14574</ArticleId><ArticleId IdType="pubmed">30144068</ArticleId></ArticleIdList></Reference><Reference><Citation>Panther L, Ornelas L, Jones MR, Gross AR, Gomez E, Liu C, Berman B, Svendsen CN, and Sareen D (2021). Generation of iPSC lines with high cytogenetic stability from peripheral blood mononuclear cells (PBMCs). 10.1101/2021.09.27.462082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.27.462082</ArticleId></ArticleIdList></Reference><Reference><Citation>ENCODE Consortium (2017). ENCODE experimental guidelines for ENCODE3 RNA-seq. https://www.encodeproject.org/about/experiment-guidelines/.</Citation></Reference><Reference><Citation>Schulze SK, Kanwar R, G&#xf6;lzenleuchter M, Therneau TM, and Beutler AS (2012). SERE: single-parameter quality control and sample comparison for RNA-Seq. BMC Genomics 13, 524. 10.1186/1471-2164-13-524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-13-524</ArticleId><ArticleId IdType="pmc">PMC3534338</ArticleId><ArticleId IdType="pubmed">23033915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman GE, and Schadt EE (2016). variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics 17, 483. 10.1186/s12859-016-1323-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-016-1323-z</ArticleId><ArticleId IdType="pmc">PMC5123296</ArticleId><ArticleId IdType="pubmed">27884101</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245&#x2013;256. 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, et al. (2013). RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415&#x2013;428. 10.1016/jneuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jneuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, B&#xe4;umer D, East S, Neal J, Morris HR, Ansorge O, and Blake DJ (2014). Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging 35, 1779.e5&#x2013;1779.e13. 10.1016/j.neurobiolaging.2014.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, Murray ME, Overstreet KK, Piazza-Johnston AE, Desaro P, et al. (2015). Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 18, 1175&#x2013;1182. 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar S, Seaton LR, Weissbein U, Eldar-Geva T, and Benvenisty N (2019). Global characterization of X chromosome inactivation in human pluripotent stem cells. Cell Rep. 27, 20&#x2013;29.e3. 10.1016/j.celrep.2019.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.019</ArticleId><ArticleId IdType="pubmed">30943402</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman P, Gubbay J, Vivian N, Goodfellow P, and Lovell-Badge R (1991). Male development of chromosomally female mice transgenic for Sry. Nature 351, 117&#x2013;121. 10.1038/351117a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/351117a0</ArticleId><ArticleId IdType="pubmed">2030730</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, McMahon MA, Beccari MS, Artates JW, et al. (2019). Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180&#x2013;190. 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, Burberry A, Steinbaugh MJ, Gamage KK, Kirchner R, et al. (2019). ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167&#x2013;179. 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, Briner A, Rodriguez CM, Guo C, Akiyama T, et al. (2022). TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature 603, 124&#x2013;130. 10.1038/s41586-022-04424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, Bampton A, Lee FCY, Masino L, Qi YA, et al. (2022). TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603, 131&#x2013;137. 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Saris CG, Horvath S, van Vught PW, van Es MA, Blauw HM, Fuller TF, Langfelder P, DeYoung J, Wokke JH, Veldink JH, et al. (2009). Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients. BMC Genomics 10, 405. 10.1186/1471-2164-10-405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-10-405</ArticleId><ArticleId IdType="pmc">PMC2743717</ArticleId><ArticleId IdType="pubmed">19712483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XS, Simmons Z, Liu W, Boyer PJ, and Connor JR (2006). Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph. Lateral Scler. 7, 201&#x2013;210. 10.1080/17482960600947689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600947689</ArticleId><ArticleId IdType="pubmed">17127558</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczniak-Ferguson A, and Ferguson SM (2019). Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis. Life Sci. Alliance 2, 2. 10.26508/lsa.201900358.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900358</ArticleId><ArticleId IdType="pmc">PMC6749094</ArticleId><ArticleId IdType="pubmed">31527135</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Atsuta N, Hirakawa A, Nakamura R, Nakatochi M, Ishigaki S, Iida A, Ikegawa S, Kubo M, Yokoi D, et al. (2016). A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J. Neurol. Neurosurg. Psychiatry 87, 851&#x2013;858. 10.1136/jnnp-2015-311541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311541</ArticleId><ArticleId IdType="pubmed">26746183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, Misawa K, Tohnai G, Nakatochi M, Furuhashi S, Atsuta N, Hayashi N, Yokoi D, Watanabe H, Watanabe H, et al. (2020). A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis. Commun. Biol. 3, 526. 10.1038/s42003-020-01251-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01251-2</ArticleId><ArticleId IdType="pmc">PMC7511394</ArticleId><ArticleId IdType="pubmed">32968195</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida A, Takahashi A, Kubo M, Saito S, Hosono N, Ohnishi Y, Kiyotani K, Mushiroda T, Nakajima M, Ozaki K, et al. (2011). A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Hum. Mol. Genet. 20, 3684&#x2013;3692. 10.1093/hmg/ddr268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr268</ArticleId><ArticleId IdType="pubmed">21665992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack AA, Kroboth S, Rajesh D, and Wang WB (2011). Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors. PLoS One 6, e27956. 10.1371/journal.pone.0027956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027956</ArticleId><ArticleId IdType="pmc">PMC3222670</ArticleId><ArticleId IdType="pubmed">22132178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kytt&#xe4;l&#xe4; A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy KK, Nakanishi M, Nishimura K, Ohtaka M, Weltner J, et al. (2016). Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential. Stem Cell Rep. 6, 200&#x2013;212. 10.1016/j.stemcr.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.12.009</ArticleId><ArticleId IdType="pmc">PMC4750096</ArticleId><ArticleId IdType="pubmed">26777058</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LR, Cho S, and Discher DE (2018). Stem cell differentiation is regulated by extracellular matrix mechanics. Physiology (Bethesda) 33, 16&#x2013;25. 10.1152/physiol.00026.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00026.2017</ArticleId><ArticleId IdType="pmc">PMC5866410</ArticleId><ArticleId IdType="pubmed">29212889</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, and Henderson RD (2010). Effects of gender in amyotrophic lateral sclerosis. Gend. Med. 7, 557&#x2013;570. 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, Dougherty A, Willey E, Stanton BR, et al. (2010). The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph. Lateral Scler. 11, 439&#x2013;442. 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, Tork C, Shelley B, McHugh J, Wallace K, Klein SM, Lindstrom MJ, and Svendsen CN (2007). Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph. Lateral Scler. 8, 20&#x2013;25. 10.1080/17482960600982447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600982447</ArticleId><ArticleId IdType="pubmed">17364431</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos D, Ram&#xed;rez-N&#xfa;&#xf1;ez O, Granado-Serrano AB, Torres P, Ayala V, Moiseeva V, Povedano M, Ferrer I, Pamplona R, Portero-Otin M, and Boada J (2016). Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS. Acta Neuropathol. Commun. 4, 3. 10.1186/s40478-015-0271-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0271-6</ArticleId><ArticleId IdType="pmc">PMC4711180</ArticleId><ArticleId IdType="pubmed">26757991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf3; A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, Ilardi A, Bertuzzo D, Bersano E, Cugnasco P, et al. (2017). Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d&#x2019;aosta register. JAMA Neurol. 74, 1097&#x2013;1104. 10.1001/jama-neurol.2017.1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama-neurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf3; A, Moglia C, Canosa A, Manera U, D&#x2019;Ovidio F, Vasta R, Grassano M, Brunetti M, Barberis M, Corrado L, et al. (2020). ALS phenotype is influenced by age, sex, and genetics: A population-based study. Neurology 94, e802&#x2013;e810. 10.1212/WNL.0000000000008869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Janiszewski A, Talon I, Chappell J, Collombet S, Song J, De Geest N, To SK, Bervoets G, Marin-Bejar O, Provenzano C, et al. (2019). Dynamic reversal of random X-chromosome inactivation during iPSC reprogramming. Genome Res. 29, 1659&#x2013;1672. 10.1101/gr.249706.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.249706.119</ArticleId><ArticleId IdType="pmc">PMC6771397</ArticleId><ArticleId IdType="pubmed">31515287</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenes AJ, Yoshikawa H, Bensaddek D, Mirauta B, Seaton D, Hukelmann JL, Jiang H, Stegle O, and Lamond AI (2021). Erosion of human X chromosome inactivation causes major remodeling of the iPSC proteome. Cell Rep. 35, 109032. 10.1016/j.celrep.2021.109032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109032</ArticleId><ArticleId IdType="pmc">PMC8097692</ArticleId><ArticleId IdType="pubmed">33910018</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchieu J, Kuoy E, Chin MH, Trinh H, Patterson M, Sherman SP, Aimiuwu O, Lindgren A, Hakimian S, Zack JA, et al. (2010). Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 7, 329&#x2013;342. 10.1016/j.stem.2010.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2010.06.024</ArticleId><ArticleId IdType="pmc">PMC2935700</ArticleId><ArticleId IdType="pubmed">20727844</ArticleId></ArticleIdList></Reference><Reference><Citation>Vawter MP, Evans S, Choudary P, Tomita H, Meador-Woodruff J, Molnar M, Li J, Lopez JF, Myers R, Cox D, et al. (2004). Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 29, 373&#x2013;384. 10.1038/sj.npp.1300337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.npp.1300337</ArticleId><ArticleId IdType="pmc">PMC3130534</ArticleId><ArticleId IdType="pubmed">14583743</ArticleId></ArticleIdList></Reference><Reference><Citation>Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, et al. (2017). Landscape of X chromosome inactivation across human tissues. Nature 550, 244&#x2013;248. 10.1038/nature24265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24265</ArticleId><ArticleId IdType="pmc">PMC5685192</ArticleId><ArticleId IdType="pubmed">29022598</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano H, and Morimoto S (2022). iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Cell Stem Cell 29, 189&#x2013;208. 10.1016/j.stem.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2022.01.007</ArticleId><ArticleId IdType="pubmed">35120619</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal NA, Berry JD, Windebank A, Staff NP, Maragakis NJ, van den Berg LH, Genge A, Miller R, Baloh RH, Kern R, et al. (2020). Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle Nerve 62, 156&#x2013;166. 10.1002/mus.26801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26801</ArticleId><ArticleId IdType="pmc">PMC7496557</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho R, Workman MJ, Mathkar P, Wu K, Kim KJ, O&#x2019;Rourke JG, Kellogg M, Montel V, Banuelos MG, Arogundade OA, et al. (2021). Cross-comparison of human iPSC motor neuron models of familial and sporadic ALS reveals early and convergent transcriptomic disease signatures. Cell Syst. 12, 159&#x2013;175.e9. 10.1016/j.cels.2020.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.10.010</ArticleId><ArticleId IdType="pmc">PMC7897311</ArticleId><ArticleId IdType="pubmed">33382996</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, and Thomson JA (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797&#x2013;801. 10.1126/science.1172482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1172482</ArticleId><ArticleId IdType="pmc">PMC2758053</ArticleId><ArticleId IdType="pubmed">19325077</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, et al. (2011). A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409&#x2013;412. 10.1038/nmeth.1591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1591</ArticleId><ArticleId IdType="pubmed">21460823</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, Goshima N, and Yamanaka S (2013). An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458&#x2013;466. 10.1002/stem.1293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1293</ArticleId><ArticleId IdType="pubmed">23193063</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>